Dental Bone Graft Substitute Market: is Eyeing to Generate Revenue at Steady Growth Rate in Near Future

What This Report Will Provide? This study involved four major activities in estimating the current size of the dental bone graft substitute market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Expected Revenue Growth: The global dental bone graft substitute market size is projected to reach USD 659 million by 2025 from USD 450 million in 2020, at a CAGR of 7.9%.

Major Growth Boosters: Growth in the dental bone graft substitute market is driven primarily by the increasing prevalence of dental disorders, continuous product commercialization, market availability & product affordability, rising number of geriatric population, and growing public awareness related to preventive care.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690 Recent Developments In Dental Bone Graft Substitute Market: 1. In 2019, Straumann and Modern Dental Group Limited (Hong Kong) entered a joint venture to create distribution company that will serve the dental communities in Hong Kong and Macau; Peak Dental Solutions Hong Kong Ltd.

2. In 2018, Dentsply acquired OraMetrix, a leading industry provider of innovative 3-D technology solutions improving the quality and efficiency of orthodontic care.

3. In 2018, Straumann acquired 30% stake in Botiss biomaterials.

Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Dental Bone Graft Substitute Market?
2. What are the drivers, restraints, opportunities, and challenges in the Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of Dental Bone Graft Substitute in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Market Driver: Growing Medical and Dental Tourism Dental tourism is an important factor that drives the dental bone graft substitutes market. India’s dental tourism service as there is a lot of cost difference with good quality work when we compared India to the other countries. Like cost for smile designing in US is USD 8,000 and in India is USD 1,000 and for dental implants in the US is USD 2,000, in Hungary is USD 1070 and in India USD 600 approximately.

Countries, such as Thailand and Malaysia, offer dental tour packages that include the cost of a dental treatment as well as a vacation, which is still lower than the total cost of a dental treatment incurred in the US or the UK. This has attracted a large number of people from America and Europe to avail dental treatments in Asian countries, thus making dental tourism a major source of revenue collection in these countries. Introduction and availability of newer and advanced dental products is expected to further fuel the growth of this market.

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=159678690

Key Players: Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US), Geistlich Pharm (Switzerland), RTI Surgical (US), BioHorizons, IPH, Inc (US), Dentium (South Korea), LifeSciences Corporation (US), Smith & Nephew (UK), Novabone LLC (US), Botiss biomaterials GmbH (US), Collagen Matrix Inc. (US), Osteogenics Biomedical (US), LifeNet Health (US), Wright Medical (US), and Stryker Corporation (US).